Photodynamic antimicrobial chemotherapy (PACT) using phenothiazine derivatives as photosensitizers against Leishmania braziliensis

Lasers in Surgery and Medicine

Volumn 44, Issue 10, 2012, Pages 850-855

  Barbosa, Artur F ^a,b,c,d   Sangiorgi, Bruno B ^b   Galdino, Suely L ^c   Barral Netto, Manoel ^b   Pitta, Ivan R ^c   Pinheiro, Antônio L ^a,e  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^d São Camilo School   (Brazil)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

laser therapy; leishmaniasis; methylene blue; toluidine blue O; treatment

Indexed keywords

PHENOTHIAZINE DERIVATIVE; PHOTOSENSITIZING AGENT;

ARTICLE; CELL VIABILITY; CHEMOTHERAPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; INCUBATION TIME; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS; LETHALITY; NONHUMAN; PHOTODYNAMIC ANTIMICROBIAL CHEMOTHERAPY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROMASTIGOTE;

HUMANS; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, CUTANEOUS; METHYLENE BLUE; PHENOTHIAZINES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TOLONIUM CHLORIDE; TRYPANOCIDAL AGENTS;

EID: 84871768510     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.22099     Document Type: Article

References (45)

1. De Muylder G, Ang KKH, Chen S, Arkin MR, Engel JC, McKerrow JH,. A screen against Leishmania intracellular amastigotes: Comparison to a promastigote screen and identification of a host cell-specific hit. PLoS Negl Trop Dis 2011; 5: e1253.
2. do Monte-Neto RL, Coelho AC, Raymond F, Légaré D, Corbeil J, Melo MN, Frézard F, Ouellette M,. Gene expression profiling and molecular characterization of antimony resistance in Leishmania amazonensis. PLoS Negl Trop Dis 2011; 5: e1167.
3. Santos DO, Coutinho MFM, Bottino CG, Vieira RT, Nascimento SB, Bernardino A, Bourguignon SC, Corte-Real S, Pinho RT, Rodrigues CR, Castro HC,. Leishmaniasis treatment-A challenge that remains: A review. Parasitol Res 2008; 103: 1-10.
4. Machado PR, Ampuero J, Guimarães LH, Villasboas L, Rocha AT, Schriefer A, Sousa RS, Talhari A, Penna G, Carvalho EM,. Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: A randomized and controlled trial. PLoS Negl Trop Dis 2010; 4 (12): e912.
5. Tavares NM, Silva RA, Costa DJ, Pitombo MA, Fukutani KF, Miranda JC, Valenzuela JG, Barral A, de Oliveira CI, Barral-Netto M, Brodskyn C,. Lutzomyia longipalpis saliva or salivary protein LJM19 Protects against Leishmania braziliensis and the saliva of its vector, lutzomyia intermedia. PLoS Negl Trop Dis 2011; 5 (5): e1169.
6. Soto J, Soto P,. Current situation and future of anti-leishmanial therapy in Colombia. Biomedica 2006; 26: 194-206.
7. Machado-Pinto J, Pinto J, da Costa CA, Genaro O, Marques MJ, Modabber F, Mayrink W,. Immunochemotherapy for cutaneous leishmaniasis: A controlled trial using killed Leishmania (Leishmania) amazonensis vaccine plus antimonial. Int J Dermatol 2002; 41: 73-78.
8. Vélez I, Lõpez L, Sánchez X, Mestra L, Rojas C, Rodríguez E,. Efficacy of miltefosine for the treatment of American cutaneous Leishmaniasis. Am J Trop Med Hyg 2010; 83: 351-356.
9. Enk CD, Fritsch C, Jonas F, Nasereddin A, Ingber A, Jaffe CL,., Ruzicka T,. Treatment of cutaneous leishmaniasis with photodynamic therapy. Arch Dermatol 2003; 139: 432-434.
10. Gardlo K, Horska Z, Enk CD, Rauch L, Megahed M, Ruzicka T, Fritsch C,. Treatment of cutaneous leishmaniasis by photodynamic therapy. J Am Acad Dermatol 2003; 48: 893-896.
11. Dutta S, Ray D, Kolli BK, Chang KP,. Photodynamic sensitization of Leishmania amazonensis in both extracellular and intracellular stages with aluminum phthalocyanine chloride for photolysis in vitro. Antimicrob Agents Chemotherap 2005; 49: 4474-4484.
12. Montanari J, Maidana C, Esteva MI, Salomon C, Morilla MJ, Romero EL,. Sunlight triggered photodynamic ultradeformable liposomes against Leishmania braziliensis are also leishmanicidal in the dark. J. Control Release 2010; 147: 368-376.
13. Nitzan Y, Wexler HM, Finegold SM,. Inactivation of anaerobic bacteria by various photosensitized porphyrins or by hemin. Curr Microbiol 1994; 29: 125-131.
14. Calzavara-Pinton PG, Venturini M, Sala R,. A comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin. J Photochem Photobiol B 2005; 78: 1-6.
15. Pluta K, Mlodawska BM, Jelen M,. Recent progress in biological activities of synthesized phenothiazines. Eur J Med Chem 2011; 46: 3179-3189.
16. Bailey MS, Lockwood DN,. Cutaneous leishmaniasis. Clin Dermatol 2007; 25: 203-211.
17. Foroumadi A, Pournourmohammadi S, Soltani F, Asgharian-Rezaee M, Dabiri S, Kharazmi A, Shafiee A,. Synthesis and in vitro leishmanicidal activity of 2-(5-nitro-2-furyl) and 2-(5-nitro-2-thienyl)-5-substituted-1,3,4-thiadiazoles. Bioorg Med Chem Lett 2005; 15: 1983-1985.
18. Zauli-Nascimento RC, Miguel DC, Yokoyama-Yasunaka JKU, Pereira LIA, Oliveira MAP, Ribeiro-Dias F, Dorta ML, Uliana SR,. In vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B. Trop Med Int Health 2010; 15: 68-76.
19. Pimentel MIF, Baptista C, Rubin EF, Vasconcellos ECF, Lyra MR, Salgueiro Mde M, Saheki MN, Rosalino CM, Madeira de F, Silva AF, Confort EM, Schubach Ade O,. American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis resistant to meglumine antimoniate, but with good response to pentamidine: A case report. Rev Soc Bras Med Trop 2011; 44: 254-256.
20. Gad F, Zahra T, Hasan T, Hamblin MR,. Photodynamic inactivation of Gram-positive pathogenic bacteria: Effect of growth phase and extracellular slime. Antimicrob Agents Chemother 2004; 48: 2173-2178.
21. Hamblin MR, Hasan T,. Photodynamic therapy: A new antimicrobial approach to infectious disease ? Photochem Photobiol Sci 2004; 3: 436-450.
22. Barbosa AFS, Soares LGP, Aciole JMS, Aciole GTS, Pitta IR, Galdino SL, Pinheiro ALB,. Evaluation of photodynamic antimicrobial therapy (PACT) against trypomastigotes of Trypanosoma cruzi: In vitro study. AIP Conf Proc 2011; 1364: 55-59.
23. Demidova TN, Hamblin MR,. Effect of cell-photosensitizer binding and cell density on microbial photoinactivation. Antimicrob Agents Chemother 2005; 49: 2329-2335.
24. Lambrechts SAG, Aalders MCG, Marle JV,. Mechanistic study of the photodynamic inactivation of Candida albicans by a cationic porphyrin. Antimicrob Agents Chemother 2005; 49: 2026-2034.
25. Dutta S, Ongarora BG, Li H, Vicente MGH, Kolli BK, Chang KP,. Intracellular targeting specificity of novel phthalocyanines assessed in a host parasite model for developing potential photodynamic medicine. PLoS ONE 2011; 6: e20786.
26. Machado AEH,. Photodynamic therapy principles, potential of application and perspectives. Quím Nova 2000; 23: 237-243.
27. Mang TS,. Lasers and light sources for PDT: Past, present and future. Photodiag Photodyn Therapy 2004; 1: 43-48.
28. Pierce LA,. Laser physics physiology. Plast Surg Nurs 1997; 17: 123-128.
29. Wainwright M, Grice NJ, Pye LEC,. Phenothiazine photosensitisers. Part II. 3 7-bis(arylamino)phenothiazines. Dyes Pigments 1999; 42: 45-51.
30. Sommer AP, Pinheiro AL, Mester AR, Franke RP, Whelan HT,. Biostimulatory windows in low-intensity laser activation: Lasers, scanners, and NASA's light-emitting diode array system. J Clin Med Laser Surg 2001; 19: 29-33.
31. Wainwright M,. The development of phenothiazinium photosensitisers. Photodiagnosis Photodyn Ther 2005; 2: 263-272.
32. Wainwright M, Mohr H, Walker W,. Phenothiazinium derivatives for pathogen inactivation in blood products. J Photochem Photobiol B 2007; 86: 45-58.
33. Wainwright M, Baptista MS,. The application of photosensitisers to tropical pathogens in the blood supply. Photodiagnosis Photodyn Ther 2011; 8: 240-248.
34. Ilanchelian M, Ramaraj R,. Binding interactions of toluidine blue O with Escherichia coli DNA: Formation of bridged structure. J Fluoresc 2011; 21: 1439-1453.
35. T'ung T,. In vitro photodynamic action of methylene blue on Trypanosoma brucei. Proc Soc Exp Biol Med 1938; 38: 29-31.
36. Ferreira CS, Bezerra RC, Pinheiro AA,. Methylene blue vital staining for Trypanosoma cruzi trypomastigotes and epimastigotes. Rev Inst Med Trop 2006; 48: 347-349.
37. Buchholz K, Comini MA, Wissenbach D, Schirmer RH, Krauth-Siegel RL, Gromer S,. Cytotoxic interactions of methylene blue with trypanosomatid-specific disulfide reductases and their dithiol products. Mol Biochem Parasitol 2008; 160: 65-69.
38. Correa JG, Fairlamb AH, Stoppani AOM,. Trypanosoma cruzi trypanothione reductase is inactivated by peroxidase-generate phenothiazine cationic radicals. Free Rad Res 2001; 34: 363-368.
39. Parveen S, Kahn MOF, Austin SE, Croft SL, Yardley V, Rock P, Douglas KT,. Antitrypanosomal, antileishmanial, and antimalarial activities of quaternary arylalkylammonium 2-amino-4-chlorophenyl phenyl sulfides, a new class of trypanothione reductase inhibitor, and of N-acyl derivatives of 2-amino-4-chlorophenyl phenyl sulfide. J Med Chem 2005; 48: 8087-8097.
40. Lima LM, Barreiro EJ,. Bioisosterism: A useful strategy for molecular modification and drug design. Curr Med Chem 2005; 12: 23-49.
41. Kim SY, Kwon OJ, Park JW,. Inactivation of catalase and superoxide dismutase by singlet oxygen derived from photoactivated dye. Biochemie 2001; 83: 437-444.
42. Khouri R, Bafica A, Silva Mda P, Noronha A, Kolb JP, Wietzerbin J, Barral A, Barral-Netto M, Van Weyenbergh J,. IFN-β Impairs superoxide-dependent parasite killing in human macrophages: Evidence for a deleterious role of SOD1 in cutaneous leishmaniasis. J Immunol 2009; 182: 2525-2531.
43. Peloi LS, Biondo CE, Kimura E, Politi MJ, Lonardoni MV, Aristides SM, Dorea RC, Hioka N, Silveira TG,. Photodynamic therapy for American cutaneous leishmaniasis: The efficacy of methylene blue in hamsters experimentally infected with Leishmania (Leishmania) amazonensis. Exp Parasitol 2011; 128: 353-356.
44. Song D, Lindoso JA, Oyafuso LK, Kanashiro EH, Cardoso JL, Uchoa AF, Tardivo JP, Baptista MS,. Photodynamic therapy using methylene blueto treat cutaneous leishmaniasis. Photomed Laser Surg 2011; 29: 711-715.
45. Capella MA, Capella L,. A light in multidrug resistance: Photodynamic treatment of multidrug-resistant tumors. J Biomed Sci 2003; 10: 361-366.